Department of Biological Sciences, Kongju National University, Gongju 32588, Republic of Korea.
Department of Neurology, Korea University Guro Hospital, College of Medicine, Korea University, 148 Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea.
Int J Mol Sci. 2024 Jun 9;25(12):6378. doi: 10.3390/ijms25126378.
Mutations in the gene are associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay disease (ARSACS) or complex clinical phenotypes of Charcot-Marie-Tooth disease (CMT). This study aimed to identify mutations in a Korean CMT cohort with cerebellar ataxia and spasticity by whole exome sequencing (WES). As a result, eight pathogenic mutations in four families were identified as the underlying causes of these complex phenotypes. The prevalence of CMT families with mutations was determined to be 0.3%. All the patients showed sensory, motor, and gait disturbances with increased deep tendon reflexes. Lower limb magnetic resonance imaging (MRI) was performed in four patients and all had fatty replacements. Of note, they all had similar fatty infiltrations between the proximal and distal lower limb muscles, different from the neuromuscular imaging feature in most CMT patients without mutations who had distal dominant fatty involvement. Therefore, these findings were considered a characteristic feature in CMT patients with mutations. Although further studies with more cases are needed, our results highlight lower extremity MRI findings in CMT patients with mutations and broaden the clinical spectrum. We suggest screening for in recessive CMT patients with complex phenotypes of ataxia and spasticity.
基因中的突变与常染色体隐性痉挛性共济失调型夏格诺克斯-萨格奈病(ARSACS)或复杂的夏科-马里-图病(CMT)临床表型有关。本研究旨在通过全外显子组测序(WES)鉴定具有小脑共济失调和痉挛的韩国 CMT 队列中的突变。结果,在四个家族中发现了八个致病性突变,这些突变是这些复杂表型的潜在原因。确定具有突变的 CMT 家族的患病率为 0.3%。所有患者均表现出感觉、运动和步态障碍,伴有深腱反射亢进。对四名患者进行了下肢磁共振成像(MRI)检查,均有脂肪替代。值得注意的是,它们在近端和远端下肢肌肉之间都有类似的脂肪浸润,与大多数没有突变的 CMT 患者的神经肌肉成像特征不同,后者以远端为主的脂肪受累为主。因此,这些发现被认为是具有突变的 CMT 患者的特征性表现。尽管需要更多病例的进一步研究,但我们的结果突出了具有突变的 CMT 患者下肢 MRI 检查结果,并拓宽了临床谱。我们建议对具有共济失调和痉挛等复杂表型的隐性 CMT 患者进行突变筛查。